http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0000756-A2

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-60
filingDate 1998-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f05ee2aaddbb311178c63ba8564a3af0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7df86fa07a7c64f0d628ac91cdee1e3
publicationDate 2000-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0000756-A2
titleOfInvention Use of levobupivacaine or ropivacaine for the manufacture of a medicament for the treatment of migraine
abstract The present invention relates to the use of levobupivacaine or ropivacaine for the manufacture of a medicament for the treatment of migraine. HE
priorityDate 1997-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92253
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590463

Total number of triples: 24.